Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Anticoagulation at the End of Life

Anticoagulation at the End of Life Letters Additional Contributions: We thank Ivan Oransky, MD (The Center for dents not enrolled in fee-for-service Medicare and those with Scientific Integrity, New York University, Arthur L. Carter Institute, New York, claims for venous thromboembolism and valvular heart dis- New York, cofounder of the Retraction Watch Database), and Alison Abritis, ease (including mechanical valves) in the 2 years before death. PhD (The Center for Scientific Integrity, Department of Environmental and This study was approved by the institutional review boards at Occupational Health, University of South Florida, Tampa, Florida, researcher at Retraction Watch Database), for critical review of the analysis. The authors Yale University and the VA Connecticut Healthcare System, also thank Arnaldo Dimagli, MD (Bristol Heart Institute, University of Bristol, which waived the need for informed consent owing to the use Bristol, United Kingdom), Giovanni Jr Soletti, MD (Department of Cardiothoracic of deidentified data. This study followed the Strengthening the Surgery, Weill Cornell Medicine, New York, New York), Cristiano Spadaccio, MD (Institute of Cardiovascular and Medical Sciences, University of Glasgow, Reporting of Observational Studies in Epidemiology (STROBE) United Kingdom), Michelle Demetres, MLIS (Samuel J. Wood Library and reporting guideline. C. V. Starr Biomedical Information Center, Weill Cornell Medicine, New http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Anticoagulation at the End of Life

Parks, Anna L.; Covinsky, Kenneth E.
JAMA Internal Medicine , Volume 181 (8) – Aug 10, 2021
Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/anticoagulation-at-the-end-of-life-Vmvr2MqQ40

References (5)

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2021.1804
Publisher site
See Article on Publisher Site

Abstract

Letters Additional Contributions: We thank Ivan Oransky, MD (The Center for dents not enrolled in fee-for-service Medicare and those with Scientific Integrity, New York University, Arthur L. Carter Institute, New York, claims for venous thromboembolism and valvular heart dis- New York, cofounder of the Retraction Watch Database), and Alison Abritis, ease (including mechanical valves) in the 2 years before death. PhD (The Center for Scientific Integrity, Department of Environmental and This study was approved by the institutional review boards at Occupational Health, University of South Florida, Tampa, Florida, researcher at Retraction Watch Database), for critical review of the analysis. The authors Yale University and the VA Connecticut Healthcare System, also thank Arnaldo Dimagli, MD (Bristol Heart Institute, University of Bristol, which waived the need for informed consent owing to the use Bristol, United Kingdom), Giovanni Jr Soletti, MD (Department of Cardiothoracic of deidentified data. This study followed the Strengthening the Surgery, Weill Cornell Medicine, New York, New York), Cristiano Spadaccio, MD (Institute of Cardiovascular and Medical Sciences, University of Glasgow, Reporting of Observational Studies in Epidemiology (STROBE) United Kingdom), Michelle Demetres, MLIS (Samuel J. Wood Library and reporting guideline. C. V. Starr Biomedical Information Center, Weill Cornell Medicine, New

Journal

JAMA Internal Medicine – American Medical Association

Published: Aug 10, 2021

There are no references for this article.